Literature DB >> 24657312

Mechanism of hepatotoxicity due to black cohosh (Cimicifuga racemosa): histological, immunohistochemical and electron microscopy analysis of two liver biopsies with clinical correlation.

Elena T Enbom1, Mary D Le2, Leslie Oesterich3, Joanne Rutgers4, Samuel W French2.   

Abstract

BACKGROUND: Consumption of herbal supplements in the developed world remains high. Cimicifuga racemosa (C. racemosa) extract, or black cohosh, is widely used as a hormone replacing and an anti-inflammatory agent, and has been shown to cause idiosyncratic hepatitis. The mechanism of acute liver injury in those cases is unclear. To date, hepatotoxic effects of C. racemosa have been studied mostly in vitro and in animal models. Data on human tissue is extremely limited, and mostly confined to histological findings of explanted livers.
METHODS: We evaluated clinical data and examined surgical diagnostic liver biopsy specimens obtained from two female patients, who developed acute submassive liver necrosis, following consumption of C. racemosa. Both patients presented with acute elevation of liver enzymes, cholestasis, absence of reactivity to hepatitis A, B and C antibodies, and weak non-specific positivity for autoimmune serological markers. Initial histological interpretation of the biopsies, with focus on hepatic parenchyma and portal tracts, was done by light microscopy, followed by special stain series and immunohistochemical studies, including Cam 5.2, AE1/AE3, reticulin, α-actin, sirius red, and PAS with diastase. Areas of prominent lymphocytic infiltration of the periportal liver plate, observed microscopically, were further evaluated by electron microscopy (EM). 4HNE adduction study, an immunofluorescent assay, was performed to detect products of the oxidative damage and their localization in the liver parenchyma.
RESULTS: Oxidative damage was evident by accumulation of 4HNE protein adducts in the cytoplasm of hepatocytes, secondary lysosomes and macrophages. We hypothesize that the adducted proteins, accumulated in the liver parenchyma, serve as autoantigens, which provoke an autoimmune response, and cause migration of lymphocytes to the affected regions. The formation of immunological synapses between hepatocytes and lymphocytes, predominantly T-lymphocytes, is demonstrated by electron microscopy. The autoimmune response induces piecemeal, or troxis necrosis of hepatocytes, a well described biological phenomenon, where lymphocytes gradually remove hepatocytes in a piecemeal fashion, slowly consuming them and leaving fragments of liver cells, or nubbins of anuclear cytoplasm of liver cell, at the interface between lymphocytes and hepatocytes.
CONCLUSION: The pattern of pathological injury of liver cells in both patients, following consumption of black cohosh, is identical to troxis necrosis, seen during autoimmune hepatitis. Recognition of the possibility of the acute hepatic injury by the herbal supplement black cohosh is essential for early accurate diagnosis, and timely patient management. Published by Elsevier Inc.

Entities:  

Keywords:  Acute hepatitis; Autoimmune hepatitis; Cimicifuga racemosa (black cohosh); Piecemeal necrosis; Troxis necrosis

Mesh:

Substances:

Year:  2014        PMID: 24657312     DOI: 10.1016/j.yexmp.2014.03.003

Source DB:  PubMed          Journal:  Exp Mol Pathol        ISSN: 0014-4800            Impact factor:   3.362


  12 in total

1.  Troxis necrosis, a novel mechanism for drug-induced hepatitis secondary to immunomodulatory therapy.

Authors:  Christina H Wei; Andrew Penunuri; George Karpouzas; Wayne Fleishman; Anuj Datta; Samuel W French
Journal:  Exp Mol Pathol       Date:  2015-08-20       Impact factor: 3.362

2.  Evaluating Sufficient Similarity of Botanical Dietary Supplements: Combining Chemical and In Vitro Biological Data.

Authors:  Kristen R Ryan; Madelyn C Huang; Stephen S Ferguson; Suramya Waidyanatha; Sreenivasa Ramaiahgari; Julie R Rice; Paul E Dunlap; Scott S Auerbach; Esra Mutlu; Tim Cristy; Jessica Peirfelice; Michael J DeVito; Stephanie L Smith-Roe; Cynthia V Rider
Journal:  Toxicol Sci       Date:  2019-12-01       Impact factor: 4.849

Review 3.  Adverse Effects of Nutraceuticals and Dietary Supplements.

Authors:  Martin J J Ronis; Kim B Pedersen; James Watt
Journal:  Annu Rev Pharmacol Toxicol       Date:  2017-10-06       Impact factor: 13.820

4.  Severe Hyponatremia Associated with Use of Black Cohosh during Prolonged Labor and Unsuccessful Home Birth.

Authors:  Matthew J Blitz; Michelle Smith-Levitin; Burton Rochelson
Journal:  AJP Rep       Date:  2016-03

5.  Atovaquone/proguanil-induced autoimmune-like hepatitis.

Authors:  Benedetta Terziroli Beretta-Piccoli; Giorgina Mieli-Vergani; Raffaela Bertoli; Luca Mazzucchelli; Charity Nofziger; Markus Paulmichl; Diego Vergani
Journal:  Hepatol Commun       Date:  2017-05-08

6.  Black Cohosh Hepatotoxicity with Autoimmune Hepatitis Presentation.

Authors:  Diana L Franco; Santosh Kale; Dora M Lam-Himlin; M Edwyn Harrison
Journal:  Case Rep Gastroenterol       Date:  2017-01-27

7.  Iron oxide magnetic nanoparticles combined with actein suppress non-small-cell lung cancer growth in a p53-dependent manner.

Authors:  Ming-Shan Wang; Liang Chen; Ya-Qiong Xiong; Jing Xu; Ji-Peng Wang; Zi-Li Meng
Journal:  Int J Nanomedicine       Date:  2017-10-17

8.  Black cohosh and liver toxicity: is there a relationship?

Authors:  Mohammed Muqeet Adnan; Muhammad Khan; Syed Hashmi; Muhammad Hamza; Sufyan AbdulMujeeb; Syed Amer
Journal:  Case Rep Gastrointest Med       Date:  2014-06-30

Review 9.  Hepatotoxicity of Herbal Supplements Mediated by Modulation of Cytochrome P450.

Authors:  Christopher Trent Brewer; Taosheng Chen
Journal:  Int J Mol Sci       Date:  2017-11-08       Impact factor: 5.923

10.  Assessment of acute, 14-day, and 13-week repeated oral dose toxicity of Tiglium seed extract in rats.

Authors:  Jun-Won Yun; Euna Kwon; Yun-Soon Kim; Seung-Hyun Kim; Ji-Ran You; Hyoung-Chin Kim; Jin-Sung Park; Jeong-Hwan Che; Sang-Koo Lee; Ja-June Jang; Hyeon Hoe Kim; Byeong-Cheol Kang
Journal:  BMC Complement Altern Med       Date:  2018-09-12       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.